Yesterday I was visiting L.A. and happened by the Walk of Fame, seeing many stars including the one of Barbra Streisand (below). Streisand has been doing interviews (see article here ) for both TV and newspapers regarding her advocacy for heart disease research for women. Interestingly, this interest of Streisand’s directly involves stem cells according to …
Every year I make predictions about what the following year will bring us in the stem cell field. For example, last year I made some predictions for 2012 and I shortly will do a post on my predictions for 2013. First, how did I do with my predictions for this year, which I made in …
I recently attend a conference in Florida called The World Stem Cell Summit. It was very enjoyable and unique in that it brings together and is open to all constituents of the stem cell world. I gave a couple talks and did an “expert” luncheon at this meeting, but what I enjoyed most was talking …
Perfect storm dodged: what are three key challenges for stem cell field going into 2013? Read More »
Today, a judge issued a complex, temporary restraining order (PDF here, provided by Celltex) regarding Texas stem cell company Celltex and Human Biostar Inc (HBI)/Biostar, former partners who are now in conflict and have sued each other. For more background see here, here, and here. Note that while both parties have sued each other, the judge’s ruling …
Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for …
Stem Cell Person of the Year Finalists: time to vote Read More »
Every year I give out a number of awards (See 2010 and 2011 awards here). I usually do them all in one post, but this year I’m doing them mostly in separate posts. This is the first post for 2012 awards and this is for Stem Cell Journal of the Year 2012. Some brief background is in order. Last …
Stem cell journal of the year 2012: Cell Stem Cell Read More »
So far in my series of eight simple reasons not to get an unlicensed stem cell treatment I’ve covered three compelling reasons: potential loss of insurance coverage for negative outcomes that could cost hundreds of thousands of dollars, failure of patient follow up by the doctors and clinics, and exclusion from future clinical trial participation. …
Every now and then a paper on stem cells lands many international headlines and also captures people’s imaginations. This seems to be the case for the recent urine stem cell paper from a team in China, which has made huge headlines. In addition to mainstream media, the paper was covered in Wired here and also by one …
Why did urine stem cell paper create global media sensation? Read More »
Have I got a stem cell for you! We hear a lot about the dangers of an increasing number of rogue stem cell clinics, but another critical trend has flown more under the radar: direct marketing of stem cells to doctors. This is big business and arguably one of the biggest threats to patients. In …
One of the most exciting types of stem cells are mesenchymal stem cells or MSCs. Although there is some debate about these cells (e.g. I once heard Irv Weissman say at a meeting he wasn’t sure they really existed as such), a consensus would seem to be that they have great potential medical potential. Perhaps …
Mapping global trends in MSC & stem cell clinical trials: unexpected findings Read More »